PAVASINI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 14.237
AS - Asia 7.294
EU - Europa 6.905
SA - Sud America 1.299
Continente sconosciuto - Info sul continente non disponibili 469
AF - Africa 200
OC - Oceania 41
AN - Antartide 1
Totale 30.446
Nazione #
US - Stati Uniti d'America 13.565
SG - Singapore 2.792
FI - Finlandia 2.336
IT - Italia 1.575
CN - Cina 1.560
BR - Brasile 1.022
DE - Germania 931
VN - Vietnam 823
HK - Hong Kong 526
GB - Regno Unito 416
BD - Bangladesh 391
CA - Canada 305
FR - Francia 299
PL - Polonia 255
JP - Giappone 212
IN - India 199
TR - Turchia 197
RU - Federazione Russa 195
UA - Ucraina 175
SE - Svezia 159
ID - Indonesia 150
NL - Olanda 148
MX - Messico 124
AR - Argentina 94
ES - Italia 78
IQ - Iraq 66
ZA - Sudafrica 59
LT - Lituania 57
BE - Belgio 50
PK - Pakistan 45
CO - Colombia 43
IL - Israele 43
EC - Ecuador 40
AT - Austria 37
AU - Australia 37
CR - Costa Rica 34
NI - Nicaragua 33
PH - Filippine 33
HN - Honduras 30
CZ - Repubblica Ceca 29
JM - Giamaica 29
GT - Guatemala 27
KR - Corea 27
SV - El Salvador 25
CW - ???statistics.table.value.countryCode.CW??? 24
MY - Malesia 24
SA - Arabia Saudita 24
SC - Seychelles 24
UZ - Uzbekistan 24
VE - Venezuela 24
AE - Emirati Arabi Uniti 23
CH - Svizzera 22
MA - Marocco 21
CL - Cile 19
PR - Porto Rico 19
TN - Tunisia 17
UY - Uruguay 17
EG - Egitto 16
IE - Irlanda 16
TT - Trinidad e Tobago 16
JO - Giordania 14
PE - Perù 14
KE - Kenya 13
NP - Nepal 13
AL - Albania 12
DK - Danimarca 12
DZ - Algeria 12
EE - Estonia 12
PY - Paraguay 12
HR - Croazia 11
PT - Portogallo 11
RO - Romania 11
BG - Bulgaria 10
GP - Guadalupe 10
SN - Senegal 10
ET - Etiopia 9
LB - Libano 9
CY - Cipro 8
IR - Iran 8
PS - Palestinian Territory 8
TH - Thailandia 8
KZ - Kazakistan 7
PA - Panama 7
TW - Taiwan 7
AZ - Azerbaigian 6
BY - Bielorussia 6
DO - Repubblica Dominicana 6
GE - Georgia 6
KG - Kirghizistan 6
MK - Macedonia 6
OM - Oman 6
BO - Bolivia 5
GY - Guiana 5
HU - Ungheria 5
KH - Cambogia 5
MD - Moldavia 5
SY - Repubblica araba siriana 5
LV - Lettonia 4
MM - Myanmar 4
NZ - Nuova Zelanda 4
Totale 29.933
Città #
Helsinki 2.185
Ashburn 2.100
Singapore 1.689
San Jose 1.144
Fairfield 714
Council Bluffs 684
Santa Clara 594
Munich 589
Beijing 515
Hong Kong 509
Woodbridge 502
Houston 407
New York 382
Ann Arbor 360
Chandler 330
Los Angeles 327
Seattle 312
Wilmington 287
Ho Chi Minh City 279
Cambridge 255
Dallas 245
Warsaw 239
Milan 224
Tokyo 201
Hanoi 199
Jacksonville 179
Ferrara 159
Lauterbourg 129
Phoenix 125
Shanghai 121
São Paulo 111
Jakarta 110
Orem 106
Princeton 104
London 99
Toronto 96
Turku 90
Izmir 88
Chicago 84
San Diego 81
Bologna 80
Rome 79
Frankfurt am Main 71
Denver 69
Mexico City 69
Atlanta 67
Brooklyn 67
Montreal 66
Buffalo 65
Nanjing 60
North Bergen 57
Chennai 56
San Francisco 51
Brussels 48
Naples 44
Boston 43
Nuremberg 43
Da Nang 40
Amsterdam 39
Washington 39
Moscow 38
Stockholm 38
Boardman 37
Rio de Janeiro 37
Bremen 35
Tianjin 35
Poplar 34
Haiphong 33
Manchester 33
The Dalles 33
Brasília 31
Hefei 31
Managua 31
Johannesburg 30
Paris 30
Mumbai 29
Columbus 27
Baghdad 25
Vilnius 25
Nanchang 24
Shenyang 23
Willemstad 23
Ankara 22
Belo Horizonte 22
San Salvador 22
Tashkent 22
Charlotte 21
Falkenstein 21
Redwood City 21
City of London 19
Florence 19
Melbourne 19
Miami 19
New Delhi 19
Newark 19
San José 19
Schiffdorf 19
Dhaka 18
Dong Ket 18
Guangzhou 18
Totale 19.146
Nome #
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.090
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 464
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 404
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 398
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 395
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 386
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 382
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 331
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 315
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 304
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 296
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 296
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 295
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 281
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 279
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 278
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 277
Uric acid and coronary artery disease: An elusive link deserving further attention 274
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 273
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 273
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 271
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 266
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 263
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 261
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 256
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 255
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 251
Anti-anginal drugs: Systematic review and clinical implications 249
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 243
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 243
Drug-based cardiovascular prevention in patients with Marfan Syndrome: a systematic review 241
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 241
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease 237
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 235
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 235
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 233
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 232
The Use of Multimodality Imaging for the Diagnosis of Myocardial Outpouchings and Invaginations: A Systematic Review 231
The role of echocardiography in pulmonary embolism for the prediction of in-hospital mortality: a retrospective study 229
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 229
Structural Abnormalities in Brugada Syndrome and Non-Invasive Cardiac Imaging: A Systematic Review 228
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment 226
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 225
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 223
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 220
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 219
Acetylcholine Use in Modern Cardiac Catheterization Laboratories: A Systematic Review 217
CHA2DS2-VASc risk factors as predictors of stroke after acute coronary syndrome: A systematic review and meta-analysis 217
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 216
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 214
Multi-domain lifestyle intervention in older adults after myocardial infarction: rationale and design of the PIpELINe randomized clinical trial 213
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 212
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 212
Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials 212
Coronary Microvascular Dysfunction: PET, CMR and CT Assessment 212
Functional (Re)Development of SYNTAX Score II 2020: Predictive Performance and Risk Assessment 210
The in vitro effects of verbascoside on human platelet aggregation 209
Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study 205
"Safe Femoral" Artery Approach in Endovascular Procedures: A Systematic Review of Its Safety and Feasibility 203
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 202
Functional coronary angiography to indicate and guide revascularization in STEMI patients with multivessel disease: Rationale and design of the AIR-STEMI trial 201
Multidomain Rehabilitation for Older Patients with Myocardial Infarction 200
Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: A systematic review and meta-analysis 198
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 197
Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study 196
Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study 196
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 195
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis 194
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 191
Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias 191
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 189
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 188
Multimodality imaging in acromegalic cardiomiopathy: a case report 187
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 186
Bioresorbable vascular scaffold overlap evaluation with optical coherence tomography after implantation with or without enhanced stent visualization system (WOLFIE study): a two-centre prospective comparison 185
Same-day transfer for the invasive strategy of patients with non-ST-segment elevation acute coronary syndrome admitted to spoke hospitals: Data from the Emilia-Romagna Regional Network 184
Dual Antiplatelet Therapy in Patients with Glucose-6-Phosphate Dehydrogenase Deficiency undergoing PCI with Drug-Eluting Stents. 183
Experience and Perceptions among Older Outpatients after Myocardial Infarction following an Exercise Intervention: A Qualitative Analysis from the PIpELINe Trial 181
High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions 181
Lipid Plaque Burden in NSTE-ACS patients with or without COPD: insights from the SCAP trial 180
Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients? 179
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 178
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 177
Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis 176
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 175
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 171
Effect of physical activity on left ventricular dimensions and function after myocardial infarction: a systematic review 170
30-Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable-Polymer Sirolimus-Eluting Ultra-Thin Stent 170
Coagulation factors and recurrence of ischemic and bleeding adverse events in patients with acute coronary syndromes 170
Treatment of Angina: Where Are We? 169
Safety and efficacy of new-generation coronary bioresorbable scaffolds 168
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 165
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 164
Enhanced stent visualization systems during PCI: A case series and review of literature 162
The impact of sex and physical performance on long-term mortality in older patients with myocardial infarction 162
The role of stress echocardiography in transcatheter aortic valve implantation and transcatheter edge-to-edge repair era: A systematic review 162
'All roads lead to Rome': the long journey of ticagrelor effect on endothelial function 159
Future of invasive and non-invasive hemodynamic assessment for coronary artery disease management 156
Intranasal Fentanyl for Acute Pain Management in Children, Adults and Elderly Patients in the Prehospital Emergency Service and in the Emergency Department: A Systematic Review 155
Beta-blockers and COPD: how can harmony be restored in a marriage in crisis? 151
Totale 24.629
Categoria #
all - tutte 134.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022745 0 0 0 0 49 61 51 73 53 73 131 254
2022/2023988 109 60 58 66 146 115 125 85 110 17 68 29
2023/20241.019 50 90 48 29 89 187 56 102 32 40 50 246
2024/20254.840 91 115 292 226 502 523 467 319 899 395 556 455
2025/202614.127 1.099 422 891 1.345 1.808 787 1.335 667 3.122 1.355 788 508
2026/20274.170 455 759 1.136 1.362 458 0 0 0 0 0 0 0
Totale 30.446